VALN
Valneva SE
$5.23
+0.14 (+2.65%)
At close · Jul 2
Market Cap
$495.45M
Shares
173,539,745
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.23
Open$5.28
Day$5.16–5.43
52W$5.04–12.25
Avg vol 30d26K
Short int169K · 0.1% float · 6.8d
Short vol19%
Last earningsSep 30, 2025
DataMay 2021–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−37% below
−
Price vs 50-day avg
−6% below
◦
RSI (14)
41 · neutral
+
MACD trend
positive
−
52-week position
3% · near low
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $6 › 200d $8 — 200d above 50d
+
Institutional flow
+11% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.10% of float · ▼ -6.7% MoM · 6.8 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
21 holders — near 3-yr high, broad support
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−37% below
Bearish
Price vs 50-day avg
−6% below
Bearish
RSI (14)
41 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
3% · near low
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+11% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.10% of float · ▼ -6.7% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
21 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $5
Now $5 · 3%
52-wk high $12
vs 200-day avg -37%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VALN
this stock
Valneva SE
|
$495.45M | -40.8% | — | — | 0.1% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VALN | +0.3% | -6.4% | -46.4% | -0.1% | -40.8% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.1% | -5.1% | -54.4% | +0.2% | -50.0% |